[HTML][HTML] Systems biology of cisplatin resistance: past, present and future
L Galluzzi, I Vitale, J Michels, C Brenner… - Cell death & …, 2014 - nature.com
The platinum derivative cis-diamminedichloroplatinum (II), best known as cisplatin, is
currently employed for the clinical management of patients affected by testicular, ovarian …
currently employed for the clinical management of patients affected by testicular, ovarian …
Systems biology of cisplatin resistance: past, present and future
L Galluzzi, I Vitale, J Michels, C Brenner… - Cell death & …, 2014 - pubmed.ncbi.nlm.nih.gov
The platinum derivative cis-diamminedichloroplatinum (II), best known as cisplatin, is
currently employed for the clinical management of patients affected by testicular, ovarian …
currently employed for the clinical management of patients affected by testicular, ovarian …
[引用][C] Systems biology of cisplatin resistance: past, present and future.
L Galluzzi, I Vitale, J Michels, C Brenner… - CELL DEATH & …, 2014 - research.unipd.it
[HTML][HTML] Systems biology of cisplatin resistance: past, present and future
L Galluzzi, I Vitale, J Michels, C Brenner… - Cell Death & …, 2014 - ncbi.nlm.nih.gov
The platinum derivative cis-diamminedichloroplatinum (II), best known as cisplatin, is
currently employed for the clinical management of patients affected by testicular, ovarian …
currently employed for the clinical management of patients affected by testicular, ovarian …
[PDF][PDF] Systems biology of cisplatin resistance: past, present and future
L Galluzzi, I Vitale, J Michels, C Brenner… - Cell Death and …, 2014 - cyberleninka.org
The platinum derivative cis-diamminedichloroplatinum (II), best known as cisplatin, is
currently employed for the clinical management of patients affected by testicular, ovarian …
currently employed for the clinical management of patients affected by testicular, ovarian …
[引用][C] Systems biology of cisplatin resistance: past, present and future
L Galluzzi, I Vitale, J Michels, C Brenner… - Cell Death & …, 2014 - cir.nii.ac.jp
Systems biology of cisplatin resistance: past, present and future | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
[PDF][PDF] Systems biology of cisplatin resistance: past, present and future
L Galluzzi, I Vitale, J Michels, C Brenner… - Cell Death and …, 2014 - scienceopen.com
The platinum derivative cis-diamminedichloroplatinum (II), best known as cisplatin, is
currently employed for the clinical management of patients affected by testicular, ovarian …
currently employed for the clinical management of patients affected by testicular, ovarian …
Systems biology of cisplatin resistance: past, present and future.
L Galluzzi, I Vitale, J Michels, C Brenner… - Cell Death & …, 2014 - europepmc.org
The platinum derivative cis-diamminedichloroplatinum (II), best known as cisplatin, is
currently employed for the clinical management of patients affected by testicular, ovarian …
currently employed for the clinical management of patients affected by testicular, ovarian …
Systems biology of cisplatin resistance: past, present and future
L Galluzzi, I Vitale, J Michels, C Brenner… - Cell Death and …, 2014 - search.proquest.com
The platinum derivative cis-diamminedichloroplatinum (II), best known as cisplatin, is
currently employed for the clinical management of patients affected by testicular, ovarian …
currently employed for the clinical management of patients affected by testicular, ovarian …
Systems biology of cisplatin resistance: past, present and future.
L Galluzzi, I Vitale, J Michels, C Brenner… - Cell Death & …, 2014 - europepmc.org
The platinum derivative cis-diamminedichloroplatinum (II), best known as cisplatin, is
currently employed for the clinical management of patients affected by testicular, ovarian …
currently employed for the clinical management of patients affected by testicular, ovarian …